Anaptysbio, Inc (ANAB): Depreciation & Amortization
$559.0K
Year ended 2025-12-31
$543.0K
Trailing 12 months to 2026-03-31
-6.1%
3-year compound annual growth
0.0%
5-year compound annual growth
+7.4%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $559.0K | -7.8% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $606.0K | -7.1% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $652.0K | -3.4% | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | $675.0K | +9.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $619.0K | +10.7% | 2024-03-11, From 2021-01-01 |
| 2020-12-31 | $559.0K | +8.8% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $514.0K | +63.2% | 2022-03-07, From 2019-01-01 |
| 2018-12-31 | $315.0K | +72.1% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $183.0K | -21.5% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $233.0K | -15.0% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $274.0K | n/a | 2018-03-05, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $10.94M | -5.1% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $10.00M | 0.0% |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | $2.70M | +13.1% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
Compare ANAB, PBYI, RCUS, IDYA side by side · Screen every company in Pharmaceutical Preparations ↗